Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

https://soho2018.org/

Session I: Chronic Myeloid Leukemia
Session II: Myelodysplastic Syndromes
Session III: Myeloproliferative Neoplasms
Session IV: Acute Lymphoblastic Leukemia
Session V: Acute Myeloid Leukemia
Plenary Sessions
Breakfast with the Expert
Session VI: Multiple Myeloma
Program of Events
Session VIII: Non-Hodgkin Lymphoma
Session IX: Chronic Lymphocytic Leukemia
Session X: Research Topics

Playback speed

10 seconds

DEBATE: Second Generation TKIs Are The Preferred Frontline Treatment Option for All CML Patients Where TFR Is The Main Goal – Con

By Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018) FEATURING Jane F. Apperley

0 views

October 23, 2018

Comments 0

Targeting CSF-1R to Manage Inflammation and Fibrosis in GVHD

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray

Session I: Chronic Myeloid Leukemia

19:21

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

CML: State of the Art Update

Feat. J. Cortés

17:26

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

ELN v NCCN: Do We Have Consensus?

Feat. C. Schiffer

14:23

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

Case Studies in TFR

Feat. D. Rea

16:17

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

When Second Generation TKIs Fail

Feat. J. Radich

13:54

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

DEBATE: Second Generation TKIs Are The Preferred Frontline Treatment…

Feat. G. Saglio

15:41

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

DEBATE: Second Generation TKIs Are The Preferred Frontline Treatment…

Feat. J. Apperley

17:02

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

Advanced CML Phase Disease: Current Management

Feat. M. Deininger

06:09

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

Oral Abstract CML-057: ENESTop 144-Week Update: Long-Term Treatment-…

Feat. T. Hughes

07:46

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

Oral Abstract CML-044: Treatment-Free Remission (TFR) in Patients wi…

Feat. M. Mauro

12:10

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

CML: Next Questions

Feat. T. Hughes